Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer

Open access
Nishizawa, Yujiro, Konno, Masamitsu, Asai, Ayumu, Koseki, Jun, Kawamoto, Koichi, Miyoshi, Norikatsu, Takahashi, Hidekazu, Nishida, Naohiro, Haraguchi, Naotsugu, Sakai, Daisuke, Kudo, Toshihiro, Hata, Taishi, Matsuda, Chu, Mizushima, Tsunekazu, Satoh, Taroh, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi · 2018 · Oncotarget

Abstract

// Yujiro Nishizawa 1, 2, * , Masamitsu Konno 2, 3, * , Ayumu Asai 2, 3 , Jun Koseki 3 , Koichi Kawamoto 1, 2 , Norikatsu Miyoshi 1 , Hidekazu Takahashi 1 , Naohiro Nishida 1 , Naotsugu Haraguchi 1 , Daisuke Sakai 2 , Toshihiro Kudo 2 , Taishi Hata 1 , Chu Matsuda 1 , Tsunekazu Mizushima 1, 4 , Taroh Satoh 2 , Yuichiro Doki 1 , Masaki Mori 1 and Hideshi Ishii 2, 3 1 Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan 2 Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan 3 Department of Disease Data Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan 4 Department of Therapeutics for Inflammatory Bowel Diseases, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan * These authors contributed equally to this work Correspondence to: Hideshi Ishii, email: hishii@gesurg.med.osaka-u.ac.jp Masaki Mori, email: mmori@gesurg.med.osaka-u.ac.jp Keywords: YTHDF1; colorectal cancer; c-MYC; proliferation; chemosensitivity Received: August 31, 2017 Accepted: October 28, 2017 Published: December 21, 2017 ABSTRACT Recent studies that have emerged on the diversity of RNA modification in tumors suggest their eligibility as bona fide targets in diagnosis and drug discovery. N6-methyladenosine (m 6 A) was first reported and is most common in epitranscriptome modification of various RNAs. The YT521-B homology (YTH) domain family are representative m6A-binding proteins, but how the YTH domain family is involved in cancer remains to be clearly understood. Given that clinical sequence data in colorectal cancer indicate that overexpression of YTHDF1 is outstanding among other family members, we studied the role of Ythdf1 and the transcriptional control of YTHDF1. Immunostaining of Ythdf1 showed that its expression was associated with various malignant tumor behaviors, such as depth, lymph node metastasis, and poorer cancer stages. The study of patient survival indicated that patients with high Ythdf1 expression had significantly poorer overall survival. The results indicated that Ythdf1 expression is an independent prognostic factor of patients. The in vitro study showed that the knockdown of YTHDF1 resulted in the suppression of cancer proliferation and sensitization to the exposure of anticancer drugs such as fluorouracil and oxaliplatin. Importantly, the study upstream of the YTHDF1 gene indicated that an oncogenic transcription factor c-Myc was associated with YTHDF1 in both expression and chromatin immunoprecipitation data. Moreover, the knockdown experiments of c-Myc showed the inhibition of YTHDF1, supporting a notion of c-Myc-driven YTHDF1 axis significance. These data suggest that m6A reader Ythdf1 plays a significant role in colorectal cancer progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.23554

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Nishizawa, Y., Konno, M., Asai, A., Koseki, J., Kawamoto, K., Miyoshi, N., Takahashi, H., Nishida, N., Haraguchi, N., Sakai, D., Kudo, T., Hata, T., Matsuda, C., Mizushima, T., Satoh, T., Doki, Y., Mori, M., & Ishii, H.
Venue
Oncotarget
Published
2017-12-21
Volume
9
Issue
7
Pages
7476-7486
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2780167957
Cited by
226
References
1
FWCI
7.86
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.